We always knew that epinephrine injectors were just the beginning.

Founded in 2011, Windgap Medical has always been patient-first and technology-focused. What began as one conversation about life-threatening allergies and the inadequacies of current medical delivery devices soon led to online surveys, patient interviews, and meetings with doctors and healthcare providers.

Through our research, we were blown away by how deeply the risk of anaphylaxis—and any medical condition requiring emergency medication—impacts the lives of patients and their families. They weren’t just limited by their medical condition, but by the limits of the medicine itself.

Every conversation we had pointed to three key concerns:

1. Shelf-life and stability
2. Portability
3. Ease of use

We learned people build their days and entire lives around their epinephrine autoinjector. They constantly worry about heat exposure, shelf-life, and user error—which means they limit where they can go, what they can carry, and what they can do.

So we set out to create an instant autoinjector that would deliver a simple, stable, and easy-to-use solution for each of these concerns—not just for epinephrine, but for as many medications as possible.

Leadership

AARON MANN

CHIEF EXECUTIVE OFFICER

Aaron has over 20 years of experience in the medical device and pharmaceutical services industries across a variety of leadership roles. Before joining Windgap as the CEO in 2023, Aaron served as the founding CEO of Kindeva Drug Delivery, a complex drug CDMO focused on respiratory and transdermal combination products. He built Kindeva in partnership with 3M and Altaris Capital Partners following 3M’s divestiture in 2019. He has prior executive leadership role at Phillips-Medisize, 3M, and Remedi SeniorCare. He holds an MBA from the Harvard Business School and a BA from Carleton College.

MICHAEL SAMAR

CHIEF FINANCIAL OFFICER

Michael brings over 20 years of experience in life sciences and biotech, serving as both a strategic partner and a financial advisor to growth-phase and impact-driven organizations while helping forge a culture of success. Prior to joining Windgap, Michael was the CFO of Assembly Biosciences. He launched his pharmaceutical finance career at Johnson & Johnson and went on to support capital raises totaling over $1B, multiple M&A transactions, and a successful IPO. He holds an MBA from Villanova University and a BSBA from Bryant University. He currently serves on the boards of Unity Biosciences and OUTbio, Inc.

BRENT BUCHINE

CHIEF BUSINESS OFFICER | CO-FOUNDER

Brent has over 15 years of experience in early-stage company formation and growth. With a background in semiconductors, Brent has created and developed core technologies in MEMs, Microfluidics, Optoelectronics, and Nanotechnology in support of the medical diagnostics and drug delivery industries. He co-founded Windgap medical to pursue life-changing drug delivery devices for complex injectables and difficult-to-mix medications. As Chief Business Officer, he focuses on pipeline growth and partnerships with customers across several treatment areas. Brent has a PhD from Georgia Tech and a Bachelor of Science from the University of Florida.

JASON DURKIN

VICE PRESIDENT, SUPPLY CHAIN

Jason brings nearly 30 years of experience in the combination products industry across a variety of injection and inhalation technologies. Before joining Windgap in 2023, Jason was instrumental in establishing and managing Takeda’s R&D supplier relationship team for both device and drug products. While at Nypro, a Jabil Company, he helped to establish their drug handling capabilities and managed the P&L for several injection systems. At Bespak, he helped develop several innovative inhalation technologies. He holds a Bachelor of Science in Business Administration from Boston University and a Mechanical Engineering degree from Wentworth Institute of Technology. 

JOHN CADIGAN

INTERIM VICE PRESIDENT, RESEARCH & DEVELOPMENT

John brings over 30 years of product development leadership experience in regulated industries. John has championed the development and approval of many internationally- and FDA-regulated diagnostic and therapeutic medical devices for worldwide markets. He has held CEO, COO, VP of Engineering/Research and Development, General Management, and other leadership positions with medical device manufacturers including Philips Healthcare and Hewlett Packard Medical. John holds two patents and earned his bachelor’s degree in Computer Science from the University of Lowell. He is an Advisory Board Member for the Kennedy College of Science at the University of Massachusetts, Lowell, and has been a Board Observer for Windgap Medical for over 10 years. 

ANTHONY WATSON

VICE PRESIDENT, REGULATORY AFFAIRS & QUALITY

Anthony has nearly 30 years of experience in the medical device, combination product, and digital health regulatory affairs field. He has built high-performing and self-sustaining regulatory teams and infrastructure in FDA, Biogen, Sanofi, and Pear Therapeutics.  He holds an MBA and Master of Science in Management Information Systems from the University of Maryland Global Campus and a Bachelor of Science in General Engineering from the United States Naval Academy.

BOARD OF DIRECTORS

Tim Krochuk
Shepherd Kaplan Krochuk

Michael Huang
Taiwania Capital Management

William McKee
Cobro Ventures

Reading Wilson
Shepherd Kaplan Krochuk

Closing the Gap

Explore our future impact on:

• Consumers
• Pharmaceutical Companies
• Drug Delivery Industry